Filing Details
- Accession Number:
- 0001628280-21-005111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-18 17:20:30
- Reporting Period:
- 2021-03-17
- Accepted Time:
- 2021-03-18 17:20:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1793294 | Ppd Inc. | PPD | Services-Commercial Physical & Biological Research (8731) | 453806427 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1802057 | Michael David Johnston | C/O Ppd, Inc. 929 North Front Street Wilmington NC | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-17 | 21,598 | $10.59 | 57,005 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-17 | 21,598 | $38.00 | 35,407 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-17 | 21,598 | $0.00 | 21,598 | $10.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
202,687 | 2027-05-11 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The option vested based on the Issuer's satisfaction of certain EBITDA-based vesting conditions.
- Represents 3,323 vested stock options and 199,364 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 33,228 stock options with an exercise price of $10.59 which are eligible to vest upon the satisfaction of certain EBITDA-based vesting conditions for fiscal year 2021.